GH
PTCT icon

GAM Holding’s PTC Therapeutics PTCT Stock Holding History

GAM Holding’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-20,700
Closed -$553K – 1150
2015
Q3 		$553K Hold
20,700
– – 0.01% 820
2015
Q2 		$996K Hold
20,700
– – 0.01% 743
2015
Q1 		$1.26M Buy
20,700
+500
+2% +$30.5K 0.02% 661
2014
Q4 		$1.05M Hold
20,200
– – 0.02% 704
2014
Q3 		$889K Hold
20,200
– – 0.01% 739
2014
Q2 		$528K Hold
20,200
– – 0.01% 820
2014
Q1 		$528K Buy
+20,200
New +$543K 0.01% 807
2013
Q4 		– Sell
-20,200
Closed -$433K – 1014
2013
Q3 		$433K Buy
+20,200
New +$351K 0.01% 826

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

GAM Holding's PTCT Position: Q4 2015 in Review

GAM Holding sold out of PTC Therapeutics (PTCT) in Q4 2015, closing a stake of 20,700 shares — an estimated $553K sold.

GAM Holding first reported a position in PTCT in Q3 2013 and held it in 8 quarters. The position peaked at $1.26M in Q1 2015. 141 funds tracked by Wall St. Rank hold PTCT as of Q4 2015.

  • GAM Holding reported no remaining PTC Therapeutics position as of Q4 2015 after selling out during the quarter.
  • GAM Holding sold 20,700 PTC Therapeutics shares in Q4 2015, an estimated $553K.
  • GAM Holding first reported a position in PTC Therapeutics in Q3 2013 and held it in 8 quarters.
  • GAM Holding's PTC Therapeutics position peaked at $1.26M in Q1 2015.
  • 141 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2015.

Based on GAM Holding's 13F filing for Q4 2015, filed 8 Feb 2016.